CSL Behring Scoops Up This U.S. Biotech for $416 Million Post author:Sam Post published:August 27, 2017 Post category:BioPharma August 28, 2017By Mark Terry, BioSpace.com Breaking News StaffMelbourne, Australia… Source: BioSpace You Might Also Like AbbVie Presents New Phase 2b Data on Upadacitinib in Atopic Dermatitis February 18, 2018 Teva Surges After Warren Buffett's Berkshire Reports $358M Stake February 14, 2018 PPD Clinical Research Associates Recognized For Excellence June 8, 2017
